Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta-Peptides”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Testing effectiveness (Phase 2)Ended earlyNCT00299988
What this trial is testing

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Weill Medical College of Cornell University 24
Not applicableStudy completedNCT07307872
What this trial is testing

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more
Amoneta Diagnostics SAS 150
Not applicableStudy completedNCT03899844
What this trial is testing

Study to Evaluate Amyloid in Blood and Imaging Related to Dementia

Who this might be right for
Alzheimer DiseaseAlzheimer Dementia
Washington University School of Medicine 1,122
Testing effectiveness (Phase 2)Study completedNCT03417986
What this trial is testing

Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers

Who this might be right for
Alzheimer Disease
Immungenetics AG 20
Testing effectiveness (Phase 2)Study completedNCT00750282
What this trial is testing

Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

Who this might be right for
Alzheimer DiseaseAmyloid Beta-Protein
Lantheus Biosciences Ltd. 422
Large-scale testing (Phase 3)Study completedNCT00905372
What this trial is testing

Effect of LY2062430 on the Progression of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,000
Very early researchStudy completedNCT01217021
What this trial is testing

Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 10
Post-approval studies (Phase 4)Study completedNCT00551161
What this trial is testing

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Northwell Health 12
Testing effectiveness (Phase 2)Looking for participantsNCT04629547
What this trial is testing

Sleep Trial to Prevent Alzheimer's Disease

Who this might be right for
SleepAlzheimer Disease
University of Minnesota 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789873
What this trial is testing

A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Galimedix Therapeutics Inc 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60
Post-approval studies (Phase 4)Study completedNCT02161458
What this trial is testing

Escitalopram Effects on CSF Amyloid Beta

Who this might be right for
Amyloid Beta Protein
University of Pennsylvania 98
Testing effectiveness (Phase 2)Study completedNCT03354143
What this trial is testing

Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

Who this might be right for
Hypertension
University of Texas Southwestern Medical Center 85
Not applicableStudy completedNCT02021682
What this trial is testing

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Washington University School of Medicine 58
Not applicableStudy completedNCT02959489
What this trial is testing

Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)

Who this might be right for
Alzheimer DiseaseAmyloid Beta-PeptidesRisk Assessment+3 more
Brigham and Women's Hospital 315
Not applicableStudy completedNCT02063217
What this trial is testing

Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction

Who this might be right for
Amyloid-beta
Washington University School of Medicine 36
Not applicableStudy completedNCT05521919
What this trial is testing

Acute Plasma Abeta Responses to Stress

Who this might be right for
Stress ReactionStress Physiology
University of Southern California 38
Early research (Phase 1)Study completedNCT00965588
What this trial is testing

Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 19
Testing effectiveness (Phase 2)Study completedNCT02646982
What this trial is testing

Candesartan's Effects on Alzheimer's Disease And Related Biomarkers

Who this might be right for
Mild Cognitive Impairment
Emory University 77
Not applicableUnknownNCT01128725
What this trial is testing

Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nice 100
Next Page